Mason Street Advisors’s Harte-Hanks HHS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-958
Closed -$16K 1517
2016
Q3
$16K Buy
958
+33
+4% +$544 ﹤0.01% 1510
2016
Q2
$15K Buy
925
+87
+10% +$1.54K ﹤0.01% 1513
2016
Q1
$21K Buy
838
+78
+10% +$2.4K ﹤0.01% 1504
2015
Q4
$25K Buy
760
+60
+9% +$2.25K ﹤0.01% 1497
2015
Q3
$25K Buy
700
+109
+18% +$4.92K ﹤0.01% 1492
2015
Q2
$35K Buy
591
+25
+4% +$1.68K ﹤0.01% 1480
2015
Q1
$44K Buy
566
+15
+3% +$1.16K ﹤0.01% 1463
2014
Q4
$43K Buy
551
+13
+2% +$850 ﹤0.01% 1860
2014
Q3
$34K Sell
538
-14
-3% -$952 ﹤0.01% 1867
2014
Q2
$40K Buy
552
+17
+3% +$1.31K ﹤0.01% 1831
2014
Q1
$47K Sell
535
-161
-23% -$12.5K ﹤0.01% 1795
2013
Q4
$54K Buy
696
+52
+8% +$4.24K ﹤0.01% 1806
2013
Q3
$57K Buy
644
+44
+7% +$4.03K ﹤0.01% 1662
2013
Q2
$52K Buy
+600
New +$49.7K ﹤0.01% 1604

Other funds holding HHS

Mason Street Advisors's HHS Position: Q4 2016 in Review

Mason Street Advisors sold out of Harte-Hanks (HHS) in Q4 2016, closing a stake of 958 shares — an estimated $16K sold.

Mason Street Advisors first reported a position in HHS in Q2 2013 and held it in 14 quarters. The position peaked at $57K in Q3 2013. 86 funds tracked by Wall St. Rank hold HHS as of Q4 2016.

  • Mason Street Advisors reported no remaining Harte-Hanks position as of Q4 2016 after selling out during the quarter.
  • Mason Street Advisors sold 958 Harte-Hanks shares in Q4 2016, an estimated $16K.
  • Mason Street Advisors first reported a position in Harte-Hanks in Q2 2013 and held it in 14 quarters.
  • Mason Street Advisors's Harte-Hanks position peaked at $57K in Q3 2013.
  • 86 funds tracked by Wall St. Rank held Harte-Hanks as of Q4 2016.

Based on Mason Street Advisors's 13F filing for Q4 2016, filed 14 Feb 2017.